These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34031333)

  • 1. Determinants of colorectal carcinoma screening amongst patients attending a public primary care health centre in Johor Bahru.
    Rizky NPH; Aznida FAA; Wan Fadhilah WI
    Med J Malaysia; 2021 May; 76(3):346-352. PubMed ID: 34031333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal screening using the immunochemical faecal occult blood test kit among the Malaysian cohort participants.
    Abdullah N; Abd Jalal N; Ismail N; Kamaruddin MA; Abd Mutalib NS; Alias MR; Mazlan L; Sagap I; Jamal R
    Cancer Epidemiol; 2020 Apr; 65():101656. PubMed ID: 31923638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a home-based colorectal cancer screening intervention in Malaysia (CRC-SIM).
    Schliemann D; Ramanathan K; Ibrahim Tamin NSB; O'Neill C; Cardwell CR; Ismail R; Kassim Z; Kee F; Su TT; Donnelly M
    BMC Cancer; 2023 Jan; 23(1):22. PubMed ID: 36609260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The factors associated with negative colonoscopy in screening subjects with positive immunochemical stool occult blood test outcomes.
    Ting PH; Lin XH; Jiang JK; Luo JC; Chen PH; Wang YP; Hsin IF; Perng CL; Hou MC; Lee FY
    J Chin Med Assoc; 2018 Sep; 81(9):759-765. PubMed ID: 29778550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term benefits and harms of early colorectal cancer screening in German individuals with familial cancer risk.
    Sroczynski G; Hallsson LR; Mühlberger N; Jahn B; Rehms R; Hoffmann S; Crispin A; Lindoerfer D; Mansmann U; Siebert U
    Int J Cancer; 2024 Feb; 154(3):516-529. PubMed ID: 37795630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 5-year evaluation of using stool-based test for opportunistic colorectal cancer screening in primary health institutions across Malaysia.
    Tamin NSI; Razalli KA; Sallahuddin SN; Chan HK; Hassan MRA
    Cancer Epidemiol; 2020 Dec; 69():101829. PubMed ID: 32998070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of colorectal tumours in asymptomatic patients with negative immunochemical faecal occult blood test results.
    Wakamura K; Kudo SE; Miyachi H; Kodama K; Hayashi S; Maeda Y; Ogawa Y; Kouyama Y; Kataoka SI; Kato K; Ichimasa K; Misawa M; Mori Y; Kudo T; Hayashi T; Ishida F; Ohkoshi S
    Mol Clin Oncol; 2015 Sep; 3(5):1019-1024. PubMed ID: 26623043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate and associated factors of refusal to perform immunochemical Faecal Occult Blood Test (iFOBT) among semi-urban communities.
    Syed Soffian SS; Safian N; Nawi AM; Ahmad SB; Chan HK; Abu Hassan MR
    PLoS One; 2021; 16(10):e0258129. PubMed ID: 34618854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer screening: comparison of transferrin and immuno fecal occult blood test.
    Chen JG; Cai J; Wu HL; Xu H; Zhang YX; Chen C; Wang Q; Xu J; Yuan XL
    World J Gastroenterol; 2012 Jun; 18(21):2682-8. PubMed ID: 22690078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organised colorectal cancer screening in Lampang Province, Thailand: preliminary results from a pilot implementation programme.
    Khuhaprema T; Sangrajrang S; Lalitwongsa S; Chokvanitphong V; Raunroadroong T; Ratanachu-Ek T; Muwonge R; Lucas E; Wild C; Sankaranarayanan R
    BMJ Open; 2014 Jan; 4(1):e003671. PubMed ID: 24435889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of immunochemical faecal occult blood test in general practice: a study protocol using a cluster-randomised stepped-wedge design.
    Juul JS; Bro F; Hornung N; Andersen BS; Laurberg S; Olesen F; Vedsted P
    BMC Cancer; 2016 Jul; 16():445. PubMed ID: 27400657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of colorectal cancer screening programme in Malaysia.
    Arunah C; Feisul IM; Nor Saleha IT; Muhammad Radzi AH
    Med J Malaysia; 2020 May; 75(3):235-239. PubMed ID: 32467538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of different screening strategies for colorectal cancer in Guangzhou, southern China: a Markov simulation analysis based on natural community screening results.
    Zhou Q; Li HL; Li Y; Gu YT; Liang YR; Liu HZ; Li K; Dong H; Chen YY; Lin GZ
    BMJ Open; 2021 Sep; 11(9):e049581. PubMed ID: 34489283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of population screening for colorectal cancer by repeated fecal occult blood test in the Netherlands.
    Denters MJ; Deutekom M; Fockens P; Bossuyt PM; Dekker E
    BMC Gastroenterol; 2009 Apr; 9():28. PubMed ID: 19393087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Intention and Uptake of Colorectal Cancer Screening after a Brief Health Education Program in a Malaysian Primary Care Setting: A Population-Based Study.
    Chan MW; Chean KY; Kader Maideen SF; Kow FP
    Asian Pac J Cancer Prev; 2021 Nov; 22(11):3475-3482. PubMed ID: 34837902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment.
    Worthington J; Lew JB; Feletto E; Holden CA; Worthley DL; Miller C; Canfell K
    PLoS One; 2020; 15(2):e0227899. PubMed ID: 32012174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of the immunofecal occult blood test for colorectal cancer screening in a large population.
    Yang H; Ge Z; Dai J; Li X; Gao Y
    Dig Dis Sci; 2011 Jan; 56(1):203-7. PubMed ID: 20458621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitators and barriers to colorectal cancer screening using the immunochemical faecal occult blood test among an average-risk population in semi-rural Malaysia: A qualitative study.
    Ramanathan K; Schliemann D; Binti Ibrahim Tamin NS; Mohan D; Donnelly M; Su TT
    PLoS One; 2022; 17(12):e0279489. PubMed ID: 36580458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The EPAGE guidelines are not an effective strategy for managing colonoscopies during the COVID-19 pandemic.
    Rodríguez-Alonso L; Rodríguez-Moranta F; Maisterra S; Botargues JM; Berrozpe A; Ruíz-Cerulla A; Suris G; Camps B; Gornals JB; Guardiola J
    Gastroenterol Hepatol; 2022 Jan; 45(1):9-17. PubMed ID: 33545240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.